Highlights Cell Biotech Co., Ltd.

Equities

A049960

KR7049960008

End-of-day quote Korea S.E. Other stock markets 23:00:00 04/07/2024 BST			5-day change	1st Jan Change
13,500 ^KRW	+1.89%		+3.37%	+20.32%

2023	Cell Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on February 18, 2022.	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Cell Biotech Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on February 18, 2022.	18/08/22	CI
Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on February 18, 2022.	18/08/22	CI
Cell Biotech Co., Ltd.'s Equity Buyback announced on February 18, 2022, has expired with 227,719 shares, representing 3.24% for KRW 3,718.70 million.	17/08/22	CI
Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on February 18, 2022.	19/05/22	CI
Cell Biotech Co., Ltd. announces an Equity Buyback for KRW 5,000 million worth of its shares.	18/02/22	CI
Cell Biotech Co., Ltd. authorizes a Buyback Plan.	17/02/22	CI
Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on July 31, 2019.	30/07/21	CI
Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on July 31, 2019.	30/07/21	CI
Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on July 31, 2019.	30/07/21	CI
Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on July 31, 2019.	30/07/21	CI
Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on July 31, 2019.	30/07/21	CI
Cell Biotech Co., Ltd.'s Equity Buyback announced on July 31, 2019, has expired with 432,381 shares, representing 5.8% for KRW 7,328 million.	28/07/21	CI
Cell Biotech Acquire a European Patent for Anticancer Protein P8 Originated from Lactobacillus rhamnosus	06/04/21	CI
Cell Biotech Co., Ltd.'s Equity Buyback Plan Extended till July 29, 2021.	28/01/21	CI
Cell Biotech Co., Ltd.'s Equity Buyback Plan Extended till January 29, 2021.	28/07/20	CI
Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on July 31, 2019.	29/06/20	CI
Psomagen and Cell Biotech to Enter into Agreement	21/06/20	CI
Tranche Update on Cell Biotech Co., Ltd.'s Equity Buyback Plan announced on July 31, 2019.	30/03/20	CI
Cell Biotech Co., Ltd.'s Equity Buyback Plan Extended till July 29, 2020.	29/01/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Cell Biotech Co., Ltd.

Equities

A049960

KR7049960008

Highlights

Filters